Literature DB >> 28853700

Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
.

Mohamed Belmouaz, Jeremy Diolez, Marc Bauwens, Fabien Duthe, Laure Ecotiere, Estelle Desport, Frank Bridoux.   

Abstract

BACKGROUND: Recent data suggest that the use of medium cut-off (MCO) dialyzers in hemodialysis (HD) promotes greater clearance and reduction ratio (RR) for myoglobin and other large-sized molecules than on-line hemodiafiltration (ol-HDF), but its effects on β2-microglobulin are not clear. We compared RR and clearances of small and middle-sized molecules between high-flux ol-HDF and MCO (Theranova) dialyzer in HD (MCO-HD) as well as nutritional parameters.
MATERIALS AND METHODS: We retrospectively analyzed 10 patients treated first with ol-HDF who were thereafter switched to MCO-HD over a 1-year period. Three dialysis sessions in each 6-month period were examined. We calculated RR and clearance of small and middle-sized molecules.
RESULTS: There was no significant difference between ol-HDF and MCO-HD for median serum albumin and prealbumin level, mean KT/V, mean urea and creatinine RR, mean β2-microglobulin (81 ± 5 vs. 81 ± 6%, p = 0.72) and myoglobin (60 ± 9% vs. 61 ± 7%, p = 0.59), RR or clearances.
CONCLUSION: The use of MCO (Theranova) dialyzer in HD produces similar removal of urea, creatinine, β2-microglobulin and myoglobin as does ol-HDF, with good tolerance profile and without modification of nutritional status.
.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28853700     DOI: 10.5414/CN109133


Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  16 in total

Review 1.  Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules.

Authors:  Martin Wolley; Meg Jardine; Colin A Hutchison
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-05       Impact factor: 8.237

Review 2.  Improving Clearance for Renal Replacement Therapy.

Authors:  Seolhyun Lee; Tammy L Sirich; Timothy W Meyer
Journal:  Kidney360       Date:  2021-07

3.  Comparison of Hemodialysis Using a Medium Cutoff Dialyzer versus Hemodiafiltration: A Controlled Cross-Over Study.

Authors:  Anna Lindgren; Erik Fjellstedt; Anders Christensson
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-10-27

4.  Expanded hemodialysis as effective alternative to on-line hemodiafiltration: A randomized mid-term clinical trial.

Authors:  Fernando Hadad-Arrascue; Lars-Göran Nilsson; Angela S Rivera; Angelito A Bernardo; Juan B Cabezuelo Romero
Journal:  Ther Apher Dial       Date:  2021-06-29       Impact factor: 2.195

5.  Middle molecule elimination in expanded haemodialysis: only convective transport?

Authors:  Nicolás Macías; Almudena Vega; Soraya Abad; Inés Aragoncillo; Ana María García-Prieto; Alba Santos; Esther Torres; Jose Luño
Journal:  Clin Kidney J       Date:  2018-12-15

6.  Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.

Authors:  Daniel E Weiner; Luke Falzon; Line Skoufos; Angelito Bernardo; Werner Beck; Mengqi Xiao; Ha Tran
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-25       Impact factor: 8.237

Review 7.  Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.

Authors:  Paola Ciceri; Mario Cozzolino
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

Review 8.  Chronic inflammation in end-stage renal disease and dialysis.

Authors:  Gabriela Cobo; Bengt Lindholm; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

9.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

10.  Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.

Authors:  Tae Hoon Kim; Seok-Hyung Kim; Tae Yeon Kim; Hae Yeul Park; Kwon Soo Jung; Moon Hyoung Lee; Jong Hyun Jhee; Jung Eun Lee; Hoon Young Choi; Hyeong Cheon Park
Journal:  BMC Nephrol       Date:  2019-12-31       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.